Literature DB >> 17363388

Spontaneous hypersensitivity in mesenteric afferent nerves of mice deficient in the sst2 subtype of somatostatin receptor.

Weifang Rong1, Wendy J Winchester, David Grundy.   

Abstract

Somatostatin is an inhibitory peptide present in abundance in the gastrointestinal (GI) tract. The effects of somatostatin are mediated through its interaction with a family of G-protein-coupled receptors, namely sst1-5. Previous evidence suggested that the sst2 receptor mediates an inhibitory role of somatostatin on GI afferent nerve sensitivity. In the present study we further evaluated mechanical and chemical sensitivity of mesenteric afferents in mice deficient in the sst2 receptor. Multi-unit recordings were made from mesenteric afferents from mouse jejunal segments perfused in vitro. Ramp distension of the jejunum up to 60 mmHg induced biphasic increases in afferent activity in both wild-type (WT) and sst2 gene knock-out (KO) mice. However, the level of afferent activity was significantly higher in the KO (n=15) compared to the WT (n=16) mice across the entire pressure range. The mesenteric afferent sensitivity to acid was evaluated by intraluminal infusion of hydrochloric acid (HCl 20 mM) for 2 min. Peak afferent discharge rate following acid infusion was significantly greater in KO (36.76 +/- 6.47 impulses s(-1), n=7) than in WT preparations (16.53 +/- 3.91 impulses s(-1), n=5, P<0.01). The response to bath-applied bradykinin (1 microm, 3 ml) was not significantly different in the KO and the WT preparations. It is interesting that in the WT preparations, octreotide inhibited both low- and high-threshold mechanosensory responses, whereas in the sst2 KO group it appeared to inhibit the low-threshold responses preferentially and failed to affect the high-threshold responses. The results of the present investigation demonstrate that sst2 deficiency is associated with exaggerated jejunal afferent sensitivity to both mechanical and chemical stimulations, suggesting that somatostatin plays an important inhibitory role in the control of visceral sensitivity by interacting with the sst2 receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363388      PMCID: PMC2075175          DOI: 10.1113/jphysiol.2006.125187

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  Tonic control of peripheral cutaneous nociceptors by somatostatin receptors.

Authors:  S M Carlton; J Du; S Zhou; R E Coggeshall
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors.

Authors:  Susan M Carlton; Junhui Du; Elyad Davidson; Shengtai Zhou; Richard E Coggeshall
Journal:  Pain       Date:  2001-02-15       Impact factor: 6.961

3.  ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease.

Authors:  Y Yiangou; P Facer; P A Baecker; A P Ford; C H Knowles; C L Chan; N S Williams; P Anand
Journal:  Neurogastroenterol Motil       Date:  2001-08       Impact factor: 3.598

4.  Somatostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat.

Authors:  C E Booth; A J Kirkup; G A Hicks; P P Humphrey; D Grundy
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

Review 5.  Inhibitory effect of somatostatin on inflammation and nociception.

Authors:  Erika Pintér; Zsuzsanna Helyes; János Szolcsányi
Journal:  Pharmacol Ther       Date:  2006-06-09       Impact factor: 12.310

6.  Increased acid-sensing ion channel ASIC-3 in inflamed human intestine.

Authors:  Y Yiangou; P Facer; J A Smith; L Sangameswaran; R Eglen; R Birch; C Knowles; N Williams; P Anand
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-08       Impact factor: 2.566

Review 7.  Drug design at peptide receptors: somatostatin receptor ligands.

Authors:  Jason P Hannon; Caroline Nunn; Barbara Stolz; Christians Bruns; Gisbert Weckbecker; Ian Lewis; Thomas Troxler; Konstanze Hurth; Daniel Hoyer
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

8.  Vanilloid receptor 1 immunoreactivity in inflamed human bowel.

Authors:  Y Yiangou; P Facer; N H Dyer; C L Chan; C Knowles; N S Williams; P Anand
Journal:  Lancet       Date:  2001-04-28       Impact factor: 79.321

Review 9.  Somatostatin and somatostatin receptor physiology.

Authors:  Philip Barnett
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

Review 10.  GDNF and somatostatin in sensory neurones.

Authors:  Marzia Malcangio
Journal:  Curr Opin Pharmacol       Date:  2003-02       Impact factor: 5.547

View more
  6 in total

1.  Hyperpolarization-activated cyclic nucleotide-gated cation channel subtypes differentially modulate the excitability of murine small intestinal afferents.

Authors:  Ying-Ping Wang; Bi-Ying Sun; Qian Li; Li Dong; Guo-Hua Zhang; David Grundy; Wei-Fang Rong
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

2.  Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.

Authors:  Agata Mulak; Muriel Larauche; Mandy Biraud; Mulugeta Million; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2014-11-05       Impact factor: 3.750

3.  Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.

Authors:  Roy Moncayo
Journal:  EJNMMI Res       Date:  2011-07-26       Impact factor: 3.138

4.  Inhibition of visceral nociceptors.

Authors:  David E Reed; L Ashley Blackshaw
Journal:  Front Pharmacol       Date:  2014-04-14       Impact factor: 5.810

Review 5.  Acupuncture for visceral pain: neural substrates and potential mechanisms.

Authors:  Shuping Chen; Shubin Wang; Peijing Rong; Junying Wang; Lina Qiao; Xiumei Feng; Junling Liu; Jianliang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-29       Impact factor: 2.629

6.  Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-11       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.